Open original FDA record ↗Recall record
- FDA identifier
- Z-0369-2017
- Company in FDA record
- Medimaps Group
- FDA classification date
- Nov 5, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The FRAX adjusted for TBS values are not correct when: The FRAX feature is activated in TBS iNsight; and TBS has been computed from a spine scan where some vertebrae were excluded.
Source facts
- Action
- Medimaps sent an Urgent Field Safety Notice letter dated October 3, 2016 to affected customers. The letter identified the affected product, problem and actions to be taken.
- Initiated
- 2016-10-03
- Root cause
- Under Investigation by firm
- Terminated
- 2017-06-07
- Distribution
- Worldwide Distribution - US Nationwide - in the states of: IL, NC, CA, DE, NY, MD, WI, MN. And the following countries: France,Thailand, Croatia, Canada, Italy, Spain, Russian Federation, Ukraine, Lithuania, South Africa, Brazil, Lebanon, Saudi Arabia, Korea, China Portugalm Iraq, Syrian Arab Republic, Czech Republic, Australia, Belgium, Austria, Romania, New Zealand, Switzerland, Hong Kong, Sweden, Mexico, Islamic Republic of Iran, Serbia, Netherlands, Denmark, and UK.
- Recall number
- Z-0369-2017
- Recall status
- Terminated
- CDRH record ID
- 150595
- FDA classified
- 2016-11-05
- Recall event number
- 75510